Coherus BioSciences Debt
CHRS Stock | USD 1.21 0.12 11.01% |
At this time, Coherus BioSciences' Net Debt is comparatively stable compared to the past year. Short Term Debt is likely to gain to about 4.2 M in 2024, whereas Short and Long Term Debt is likely to drop slightly above 199.2 K in 2024. . Coherus BioSciences' financial risk is the risk to Coherus BioSciences stockholders that is caused by an increase in debt.
Debt Ratio | First Reported 2010-12-31 | Previous Quarter 0.75185196 | Current Value 0.45 | Quarterly Volatility 0.31157905 |
Coherus |
Coherus BioSciences Bond Ratings
Coherus BioSciences financial ratings play a critical role in determining how much Coherus BioSciences have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Coherus BioSciences' borrowing costs.Piotroski F Score | 3 | Frail | View |
Beneish M Score | (1.49) | Possible Manipulator | View |
Coherus BioSciences Debt to Cash Allocation
Many companies such as Coherus BioSciences, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Coherus BioSciences currently holds 480.84 M in liabilities. Coherus BioSciences has a current ratio of 3.11, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Coherus BioSciences' use of debt, we should always consider it together with its cash and equity.Coherus BioSciences Common Stock Shares Outstanding Over Time
Coherus BioSciences Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Coherus BioSciences uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Coherus BioSciences Debt Ratio | 45.0 |
Coherus BioSciences Corporate Bonds Issued
Coherus Short Long Term Debt Total
Short Long Term Debt Total |
|
Understaning Coherus BioSciences Use of Financial Leverage
Coherus BioSciences' financial leverage ratio measures its total debt position, including all of its outstanding liabilities, and compares it to Coherus BioSciences' current equity. If creditors own a majority of Coherus BioSciences' assets, the company is considered highly leveraged. Understanding the composition and structure of Coherus BioSciences' outstanding bonds gives an idea of how risky it is and if it is worth investing in.
Last Reported | Projected for Next Year | ||
Short and Long Term Debt Total | 480.8 M | 248.2 M | |
Net Debt | 378 M | 396.8 M | |
Short Term Debt | 2.1 M | 4.2 M | |
Long Term Debt | 473.4 M | 497 M | |
Short and Long Term Debt | 209.7 K | 199.2 K | |
Long Term Debt Total | 259.4 M | 230.6 M | |
Net Debt To EBITDA | (1.95) | (1.85) | |
Debt To Equity | (2.45) | (2.32) | |
Interest Debt Per Share | 5.46 | 5.73 | |
Debt To Assets | 0.75 | 0.45 | |
Long Term Debt To Capitalization | 1.69 | 1.78 | |
Total Debt To Capitalization | 1.69 | 1.78 | |
Debt Equity Ratio | (2.45) | (2.32) | |
Debt Ratio | 0.75 | 0.45 | |
Cash Flow To Debt Ratio | (0.37) | (0.39) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Coherus Stock Analysis
When running Coherus BioSciences' price analysis, check to measure Coherus BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coherus BioSciences is operating at the current time. Most of Coherus BioSciences' value examination focuses on studying past and present price action to predict the probability of Coherus BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coherus BioSciences' price. Additionally, you may evaluate how the addition of Coherus BioSciences to your portfolios can decrease your overall portfolio volatility.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.